Skip to main content

Table 2 Pharmacokinetic parameters of MBZ-OS and MBZ-1% tragacanth in plasma and tissues of mice after oral administration at a single dose of 25 mg/kg

From: An alternative mebendazole formulation for cystic echinococcosis: the treatment efficacy, pharmacokinetics and safety in mice

Plasma, Parasite and Tissues

Mean value (SD) of pharmacokinetic parameters (MBZ-1% tragacanth/MBZ-OS)

Tmaxa(h)

Cmaxb(μg/ml or μg/g)

AUC0-tc(μg/ml × h or μg/g × h)

Fd

Plasma

2.6 (1.1)

3.3 (1.1)

0.7 (0.2)

4.1 (1.7)

3.8 (1.9)

27.1 (0.9)

7.1

Parasite

Cyst wall

0.8 (0.3)

6.7 (2.3)

1.1 (0.7)

0.7 (0.3)

5.8 (2.0)

13.4 (4.1)

2.3

Cyst fluid

1.0 (0)

8.0 (0)

0.011 (0.002)

0.031 (0.004)

0.069 (0.011)

0.50 (0.03)

7.3

Tissues

Liver

1.1 (0.9)

3.1 (4.3)

3.1 (2.7)

4.1 (3.8)

10.9 (11.1)

19.4 (3.6)

1.8

Lung

7.3 (7.5)

4.0 (3.4)

12.1 (12.0)

50.2 (14.2)

49.6 (47.6)

459.7 (133.1)

9.3

Spleen

2.1 (1.8)

11.3 (8.1)

4.7 (2.1)

10.6 (1.4)

37.5 (28.0)

135.3 (49.5)

3.6

Kidney

1.2 (0.8)

9.2 (6.1)

7.3 (2.1)

7.6 (2.0)

94.1 (24.4)

137.8 (38.9)

1.5

Intestine

3.0 (1.7)

1.1 (0.9)

44.0 (39.2)

7.8 (1.8)

256.2 (233.9)

28.2 (13.6)

0.1

Heart

13.4 (12.1)

3.5 (4.0)

2.4 (1.4)

3.3 (0.6)

28.2 (4.0)

43.9 (4.1)

1.6

brain

8.7 (7.0)

6.0 (3.5)

0.2 (0.3)

0.5 (0.1)

0.7 (0.3)

3.8 (0.06)

5.4

  1. a: Tmax was time to the drug peak concentration.
  2. b: Cmax was the peak concentration of the drug.
  3. c: AUC0-t was the area under the drug concentration-time curve.
  4. d: F (relative bioaviability) = AUC0-t of MBZ-1% tragacanth/AUC0-t of MBZ-OS.